摘要
目的:观察缬沙坦对慢性移植物抗宿主病(cGVHD)狼疮样肾炎小鼠肾组织中基质金属蛋白酶-9(MMP-9)、组织金属蛋白酶抑制剂-1(TIMP-1)表达的干预作用,探讨缬沙坦对肾脏的保护机制。方法:18只B6D2F1代杂交鼠,随机分为狼疮肾炎模型组(12只)和对照组(6只)。随机将狼疮肾炎模型组分为模型组(6只)和缬沙坦组(6只)。双缩脲法测定24h尿蛋白量;免疫组织化学染色法及反转录-聚合酶链反应(RT-PCR)法观察肾组织中MMP-9、TIMP-1表达;明胶酶谱法检测MMP-9活性。结果:与对照组相比,狼疮肾炎模型组小鼠24h尿蛋白量、MMP-9、TIMP-1表达及比值均增加,MMP-9活性增强,且与系膜细胞增殖呈正相关;与模型组相比,缬沙坦组尿蛋白量、MMP-9、TIMP-1表达及比值均降低,MMP-9活性下降。结论:缬沙坦降低MMP-9、TIMP-1表达及MMP-9活性,改善MMP-9/TIMP-1失衡,从而发挥肾脏保护作用。
OBJECTIVE The aim of the present study was to determine whether Valsartan affects the expressions of matrix metalloproteinase-9(MMP-9)and tissue inhibitor of metalloproteinase-1 (TIMP-1)in kidney tissue of murine chronic graft-versus-host disease lupus nephritis and evaluate the renoprotective effect of Valsartan. METHODS Eighteen female age-matched (C57BL/6J × DBA/2) F1 mice were randomly divided into two groups., control mice and cGVHD mice. The cGVHD mice were randomly divided into two groups: untreated mice, treated mice with Valsartan. The levels of urinary protein were measured in the 24 h urine collections using the blure T. protein assay as a marker of renal damage. Immunohistochemistry and RT-PCR were used to observe the expressions of MMP-9, TIMP-1 in kidney tissue. Gelatin zymography was employed to perform MMP-9 activity examination. RESULTS Urinary protein excretion was increased significantly in cGVHD mice compared with the control mice. The cGVHD mice were found to have markedly intense staining of MMP-9, TIMP-1 mainly in tubular epithelial cells and walls of vessels. The level of glomerular MMP-9 staining correlated significantly with the level of total glomerular cell proliferation. The cGVHD mice displayed instinctively upregulated the ratio of MMP-9/TIMP-1 and increased MMP-9 activity. The treated mice had less proteinuria than untreated mice. The rate of MMP-9/TIMP-1 and gelatinolytic activity of MMP-9 in treated-mice were significantly reduced. CONCLUSION The imbalance of MMP-9 and TIMP-1 will lead to the regression of renal in lupus nephritis. Valsartan plays an important role in the regulation of the balance of MMP-9 and TIMP-1, which will prevent progressive kidney failure of lupus nephritis.
出处
《中国医院药学杂志》
CAS
CSCD
北大核心
2009年第2期105-110,共6页
Chinese Journal of Hospital Pharmacy